BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37446046)

  • 21. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
    Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
    J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.
    Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
    Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updates on sphingolipids: Spotlight on retinopathy.
    Shiwani HA; Elfaki MY; Memon D; Ali S; Aziz A; Egom EE
    Biomed Pharmacother; 2021 Nov; 143():112197. PubMed ID: 34560541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.
    Laviad EL; Albee L; Pankova-Kholmyansky I; Epstein S; Park H; Merrill AH; Futerman AH
    J Biol Chem; 2008 Feb; 283(9):5677-84. PubMed ID: 18165233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sphingolipid metabolism disorders on endothelial cells.
    Lai Y; Tian Y; You X; Du J; Huang J
    Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine-1-Phosphate Signaling and Metabolism Gene Signature in Pediatric Inflammatory Bowel Disease: A Matched-case Control Pilot Study.
    Suh JH; Degagné É; Gleghorn EE; Setty M; Rodriguez A; Park KT; Verstraete SG; Heyman MB; Patel AS; Irek M; Gildengorin GL; Hubbard NE; Borowsky AD; Saba JD
    Inflamm Bowel Dis; 2018 May; 24(6):1321-1334. PubMed ID: 29788359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal plasma and amniotic fluid sphingolipids profiling in fetal Down syndrome.
    Charkiewicz K; Blachnio-Zabielska A; Zbucka-Kretowska M; Wolczynski S; Laudanski P
    PLoS One; 2015; 10(5):e0127732. PubMed ID: 26000716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
    Wang G; Bieberich E
    Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
    Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
    Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis.
    Maceyka M; Payne SG; Milstien S; Spiegel S
    Biochim Biophys Acta; 2002 Dec; 1585(2-3):193-201. PubMed ID: 12531554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia.
    Wątek M; Durnaś B; Wollny T; Pasiarski M; Góźdź S; Marzec M; Chabowska A; Wolak P; Żendzian-Piotrowska M; Bucki R
    Lipids Health Dis; 2017 Dec; 16(1):235. PubMed ID: 29216917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides.
    Trayssac M; Clarke CJ; Stith JL; Snider JM; Newen N; Gault CR; Hannun YA; Obeid LM
    Cell Death Dis; 2021 Jan; 12(1):27. PubMed ID: 33414460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramides and sphingosine-1-phosphate mediate the distinct effects of M1/M2-macrophage infusion on liver recovery after hepatectomy.
    Sun H; Sun S; Chen G; Xie H; Yu S; Lin X; Qian J; Mao C; Peng H; Chen H; Chen X; Li Y; Liu C; Shi J; Zhu B; Guo L; Li Q; Huang P; Wei Y; Huang X; Liu M; Cui Z; Zhang Q; Zhou J; Li C; Wang K
    Cell Death Dis; 2021 Mar; 12(4):324. PubMed ID: 33771984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids.
    Uranbileg B; Kurano M; Kano K; Sakai E; Arita J; Hasegawa K; Nishikawa T; Ishihara S; Yamashita H; Seto Y; Ikeda H; Aoki J; Yatomi Y
    Clin Transl Med; 2022 Sep; 12(9):e1056. PubMed ID: 36125914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingolipids as a new factor in the pathomechanism of preeclampsia - Mass spectrometry analysis.
    Charkiewicz K; Goscik J; Blachnio-Zabielska A; Raba G; Sakowicz A; Kalinka J; Chabowski A; Laudanski P
    PLoS One; 2017; 12(5):e0177601. PubMed ID: 28542236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitization.
    Separovic D; Joseph N; Breen P; Bielawski J; Pierce JS; Buren EV; Bhatti G; Saad ZH; Bai A; Bielawska A
    Biochem Biophys Res Commun; 2011 Jun; 409(3):372-7. PubMed ID: 21545791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
    Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
    Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.
    Majumdar I; Mastrandrea LD
    Endocrine; 2012 Jun; 41(3):442-9. PubMed ID: 22228496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.